Thursday, October 28, 2021

That's convenient.

Apparently a common antidepressant seems to have therapeutic value in treating the 'Rona, possibly tied to its side-effect as an anti-inflammatory.
A widely available antidepressant holds promise as a treatment for Covid-19, according to a new study.

Covid-19 patients who received fluvoxamine were significantly less likely to require hospitalization than those who didn’t, in the largest clinical trial evaluating the antidepressant’s effect on Covid-19 to date.
Not only would it decrease the chance of severe symptoms requiring hospitalization, I guess even if you do wind up in the hospital, you're less likely do be sad about it!